MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease.

Hegemann, Inga; Sasselli, Clelia; Valeri, Fabio; Makhro, Asya; Müller, Rouven; Bogdanova, Anna; Manz, Markus G; Gassmann, Max; Goede, Jeroen S.

Afiliação

Hegemann I; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
Sasselli C; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
Valeri F; Institute of Primary Care, University of Zurich, Zurich, Switzerland.
Makhro A; Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Müller R; Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
Bogdanova A; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
Manz MG; Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Gassmann M; Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
Goede JS; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.

Hemasphere ; 4(4): e452, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32885144

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article